These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8551603)

  • 1. Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells.
    Dalal S; Gao Q; Androphy EJ; Band V
    J Virol; 1996 Feb; 70(2):683-8. PubMed ID: 8551603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells.
    Liu Y; Chen JJ; Gao Q; Dalal S; Hong Y; Mansur CP; Band V; Androphy EJ
    J Virol; 1999 Sep; 73(9):7297-307. PubMed ID: 10438818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hAda3 degradation by papillomavirus type 16 E6 correlates with abrogation of the p14ARF-p53 pathway and efficient immortalization of human mammary epithelial cells.
    Shamanin VA; Sekaric P; Androphy EJ
    J Virol; 2008 Apr; 82(8):3912-20. PubMed ID: 18256148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells.
    Gao Q; Singh L; Kumar A; Srinivasan S; Wazer DE; Band V
    J Virol; 2001 May; 75(9):4459-66. PubMed ID: 11287601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells.
    Band V; Dalal S; Delmolino L; Androphy EJ
    EMBO J; 1993 May; 12(5):1847-52. PubMed ID: 8387914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity.
    Sedman SA; Hubbert NL; Vass WC; Lowy DR; Schiller JT
    J Virol; 1992 Jul; 66(7):4201-8. PubMed ID: 1318401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7.
    Wazer DE; Liu XL; Chu Q; Gao Q; Band V
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3687-91. PubMed ID: 7537374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation.
    Gao Q; Srinivasan S; Boyer SN; Wazer DE; Band V
    Mol Cell Biol; 1999 Jan; 19(1):733-44. PubMed ID: 9858596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro.
    Nakagawa S; Watanabe S; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    Virology; 1995 Oct; 212(2):535-42. PubMed ID: 7571423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification.
    Hiller T; Poppelreuther S; Stubenrauch F; Iftner T
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1262-7. PubMed ID: 16835321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKN binds and phosphorylates human papillomavirus E6 oncoprotein.
    Gao Q; Kumar A; Srinivasan S; Singh L; Mukai H; Ono Y; Wazer DE; Band V
    J Biol Chem; 2000 May; 275(20):14824-30. PubMed ID: 10809724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activation by the E6 gene product of human papillomavirus type 16.
    Klingelhutz AJ; Foster SA; McDougall JK
    Nature; 1996 Mar; 380(6569):79-82. PubMed ID: 8598912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells.
    Halbert CL; Demers GW; Galloway DA
    J Virol; 1992 Apr; 66(4):2125-34. PubMed ID: 1312623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells.
    Band V; De Caprio JA; Delmolino L; Kulesa V; Sager R
    J Virol; 1991 Dec; 65(12):6671-6. PubMed ID: 1658367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes.
    Liu X; Disbrow GL; Yuan H; Tomaic V; Schlegel R
    J Virol; 2007 Nov; 81(22):12689-95. PubMed ID: 17804506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immortalization of human mammary epithelial cells is associated with inactivation of the p14ARF-p53 pathway.
    Shamanin VA; Androphy EJ
    Mol Cell Biol; 2004 Mar; 24(5):2144-52. PubMed ID: 14966292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
    Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L
    Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts.
    Shay JW; Wright WE; Brasiskyte D; Van der Haegen BA
    Oncogene; 1993 Jun; 8(6):1407-13. PubMed ID: 8389027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.
    Slebos RJ; Kessis TD; Chen AW; Han SM; Hedrick L; Cho KR
    Virology; 1995 Apr; 208(1):111-20. PubMed ID: 11831691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6.
    Gardiol D; Banks L
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1963-70. PubMed ID: 9714244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.